Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-25-001028
Filing Date
2025-07-16
Accepted
2025-07-16 09:27:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 e664698_f6pos-nucana.htm F-6 POS 51741
2 e664698_ex99-ai.htm EX-99.(A)(I) 199286
3 e664698_ex99-aii.htm EX-99.(A)(II) 462506
  Complete submission text file 0001193805-25-001028.txt   715152
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS
(CF Office: International Corp Fin)

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-286737 | Film No.: 251126289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)